• Latest News
  • GSK and Plasticell to manufacture haematopoietic cells from iPSC

    19/10/2017 GSK has entered a collaboration to use UK-based firm Plasticell’s combinatorial stem cell screening technology, CombiCult, to develop haematopoietic cells from induced pluripotent stem cells (iPSC). Plasticell is a biotechnology company that specialises in stem cell screening and the... read more


Funding Partners: